metformin hydrochloride 1000 MG / rosiglitazone (as rosiglitazone maleate) 2 MG Oral Tablet
- RxCUI
- 861760
- RxNorm name
- metformin hydrochloride 1000 MG / rosiglitazone (as rosiglitazone maleate) 2 MG Oral Tablet
- Display name
- metformin hydrochloride 1000 MG / rosiglitazone (as rosiglitazone maleate) 2 MG Oral Tablet
- Full name
- metformin hydrochloride 1000 MG / rosiglitazone (as rosiglitazone maleate) 2 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fd | rosiglitazone maleate 2 MG / metFORMIN HCl 1000 MG Oral Tablet [PSN] · metformin hydrochloride 1000 MG / rosiglitazone 2 MG Oral Tablet [SCD] · metformin hydrochloride 1000 MG / rosiglitazone (as rosiglitazone maleate) 2 MG Oral Tablet [SY] | 3 | 6 | These highlights do not include all the information needed to use AVANDAMET safely and effectively. See full prescribing information for AVANDAMET. AVANDAMET (rosiglitazone maleate and metformin hydrochloride) Tablets Initial U.S. Approval: 2002 | 20120830 |